The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index.
Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy
Abstract
Glycosylated pH-sensitive mesoporous silica nanoparticles (MSNs) of capecitabine (CAP) were developed for targeting colorectal cancer. The MSNs possessed an average pore diameter of 8.12 ± 0.43 nm, pore volume of 0.73 ± 0.21 cm 3/g, and particle size of 245.24 ± 5.75 nm. A high loading of 180.51 ± 5.23 mg/g attributed to the larger pore volume was observed. The surface of the drug-loaded MSNs were capped with chitosan-glucuronic acid (CHS-GCA) conjugate to combine two strategies viz. pH-sensitive, and lectin receptor mediated uptake. In vitro studies demonstrated a pH-sensitive and controlled release of CAP which was further enhanced in the presence of rat caecal content. Higher uptake of the (CAP-MSN)CHS-GCA was observed in HCT 116 cell lines. The glycosylated nanoparticles revealed reduction in the tumors, aberrant crypt foci, dysplasia and inflammation, and alleviation in the toxic features. This illustrated that the nanoparticles showed promising antitumor efficacy with reduced toxicity and may be used as a effective carrier against cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
Haggar, F. A., & Boushey, R. P. (2009) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0029-1242458 · Cited by 2,078
Acidic extracellular microenvironment and cancer
Kato, Y., Ozawa, S., Miyamoto, C., Maehata, Y., Suzuki, A., Maeda, T., & Baba, Y. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-89 · Cited by 1,295
The Acidic Tumor Microenvironment as a Driver of Cancer
Boedtkjer, E., & Pedersen, S. F. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034627 · Cited by 1,293
Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances
Narayan, R., Nayak, U. Y., Raichur, A. M., & Garg, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030118 · Cited by 987
Self-citation5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Vodenkova, S., Buchler, T., Cervena, K., Veskrnova, V., Vodicka, P., & Vymetalkova, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107447 · Cited by 956
Walko, C. M., & Lindley, C. M. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.01.005 · Cited by 679
Strategies to Modify the Drug Release from Pharmaceutical Systems
(2015) · Elsevier eBooks · doi:10.1016/c2014-0-02342-8 · Cited by 623
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property
Charnay, C., Bégu, S., Tourné‐Péteilh, C., Nicole, L., Lerner, D. A., & Devoisselle, J. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.12.007 · Cited by 517
Kumar, S., & Koh, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13056102 · Cited by 484
The acidic tumor microenvironment: a target for smart cancer nano-theranostics
Feng, L., Dong, Z., Tao, D., Zhang, Y., & Liu, Z. (2017) · National Science Review · doi:10.1093/nsr/nwx062 · Cited by 430
Cited by
Sorted by citations
Preparation and application of pH-responsive drug delivery systems
Ding, H., Tan, P., Fu, S., Tian, X., Zhang, H., Ma, X., Gu, Z., & Luo, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.056 · Cited by 645
An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine
Rastegari, E., Hsiao, Y., Lai, W.-Y., Lai, Y.-H., Yang, T., Chen, S., Huang, P., Chiou, S., Mou, C., & Chien, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071067 · Cited by 136
Djayanti, K., Maharjan, P., Cho, K. H., Jeong, S., Kim, M. S., Shin, M. C., & Min, K. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076349 · Cited by 129
Nanoparticle-based materials in anticancer drug delivery: Current and future prospects
Ajith, S., AlMomani, F. A., Elhissi, A. M. A., & Husseini, G. A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21227 · Cited by 125
Pooresmaeil, M., Asl, E. A., & Namazi, H. (2021) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2021.160992 · Cited by 114
Recent Technologies for Amorphization of Poorly Water-Soluble Drugs
Kim, D., Kim, Y., Tin, Y. Y., Soe, M.-T.-P., Ko, B. H., Park, S., & Lee, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081318 · Cited by 99
Wang, Z., Wang, S., He, Q., Yang, X., Zhao, B., Zhang, H., & Deng, Y. (2025) · ISME Communications · doi:10.1093/ismeco/ycaf133 · Cited by 93
Narayana, S., Gowda, B. H. J., Hani, U., Shimu, S. S., Paul, K., Das, A., Ashique, S., Ahmed, M. G., Tarighat, M. A., & Abdi, G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02701-3 · Cited by 87
Fernandes, N. B., Nayak, Y., Garg, S., & Nayak, U. Y. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214977 · Cited by 83
Self-citationPolymeric functionalization of mesoporous silica nanoparticles: Biomedical insights
Nair, A., Hariharapura, R. C., Day, C. M., Garg, S., Nayak, Y., Shenoy, P. A., & Nayak, U. Y. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124314 · Cited by 75
Self-citationEmerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy
Dongsar, T. T., Dongsar, T. S., Gupta, N., Almalki, W. H., Sahebkar, A., & Kesharwani, P. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104371 · Cited by 74
Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: A review
Kuang, Y., Zhai, J., Xiao, Q., Zhao, S., & Li, C. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.142 · Cited by 64
Recent Advances in Stimuli-Responsive Doxorubicin Delivery Systems for Liver Cancer Therapy
Radu, E. R., Semenescu, A., & Voicu, Ș. I. (2022) · Polymers · doi:10.3390/polym14235249 · Cited by 61
Computational modeling for the design and development of nano based drug delivery systems
Ashwini, T., Narayan, R., Shenoy, P. A., & Nayak, U. Y. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.120596 · Cited by 58
Self-citationTargeting the Gut: A Systematic Review of Specific Drug Nanocarriers
Garbati, P., Picco, C., Magrassi, R., Signorello, P., Cacopardo, L., Serra, M. D., Faticato, M. G., Luca, M. D., Balestra, F., Scavo, M. P., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030431 · Cited by 53
de Paula, M. C., Carvalho, S. G., Silvestre, A. L. P., dos Santos, A. M., Meneguin, A. B., & Chorilli, M. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121257 · Cited by 50
Shao, H., Liu, M., Jiang, H., & Zhang, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139177 · Cited by 46
Yasmin, T., Mahmood, A., Farooq, M., Sarfraz, R. M., Boublia, A., Rehman, U., Ashraf, M. U., Bhutto, J. K., Ernst, B., Albrahim, M. A., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131832 · Cited by 43
Mesoporous silicas in materials engineering: Nanodevices for bionanotechnologies
Mazzotta, E., Santo, M. D., Lombardo, D., Leggio, A., & Pasqua, L. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100472 · Cited by 41
İlgar, M., Karakuş, S., & Kilislioğlu, A. (2021) · Polymer Bulletin · doi:10.1007/s00289-021-03839-y · Cited by 41
Acid-sensitive prodrugs; a promising approach for site-specific and targeted drug release
Nazli, A., Khan, M. Z. I., Rácz, Á., & Béni, S. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116699 · Cited by 38
Drug delivery systems for colorectal cancer chemotherapy
Chen, W., Shi, K. Y., Yu, Y., Yang, P., Bei, Z., Mo, D., Yuan, L., Pan, M., Chen, Y., & Qian, Z. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109159 · Cited by 36
Day, C. M., Sweetman, M. J., Song, Y., Plush, S. E., & Garg, S. (2021) · Applied Sciences · doi:10.3390/app11136121 · Cited by 35
Self-citationMultifunctional Role of Silica in Pharmaceutical Formulations
Gao, Y., Zhang, Y., Hong, Y., Wu, F., Shen, L., Wang, Y., & Lin, X. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02237-5 · Cited by 33
Implantable smart hyperthermia nanofibers for cancer therapy: Challenges and opportunities
Valizadeh, A., Asghari, S., Abbaspoor, S., Jafari, A., Raeisi, M., & Pilehvar‐Soltanahmadi, Y. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1909 · Cited by 32
Smart Mesoporous Silica Nanoparticles Loading Curcumin Inhibit Liver Cancer
Man, S., Liu, W., Bi, J., Bai, J., Wu, Q., Hu, B., Jing Hua, H. U., & Ma, L. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c08202 · Cited by 31
Paliwal, S., Jana, P., Singh, S., Madhyastha, H., Webster, T. J., & Dev, A. (2022) · Materials Today Communications · doi:10.1016/j.mtcomm.2022.104590 · Cited by 30
Tuning Mesoporous Silica Nanoparticles in Novel Avenues of Cancer Therapy
Shah, S., Famta, P., Bagasariya, D., Charankumar, K., Sikder, A., Kashikar, R., Kotha, A. K., Chougule, M. B., Khatri, D. K., Asthana, A., et al. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00374 · Cited by 30
Zarkesh, K., Heidari, R., Iranpour, P., Azarpira, N., Ahmadi, F., Mohammadi‐Samani, S., & Farjadian, F. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103903 · Cited by 30
pH-responsive glycodendrimer as a new active targeting agent for doxorubicin delivery
Soltani, A., Faramarzi, M., Farjadian, F., Parsa, S. A. M., & Panahi, H. A. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.037 · Cited by 26
Mikayilov, E., Zeynalov, N. A., Taghiyev, D., & Taghiyev, S. (2024) · Chemical and Biochemical Engineering Quarterly · doi:10.15255/cabeq.2024.2290 · Cited by 24
Strategies of nanomedicine for targeting the signaling pathways of Colorectal cancer
Habeeb, M., You, H. W., Aher, K. B., Bhavar, G. B., Khot, V. S., & Mishra, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104487 · Cited by 24
Yasmin, T., Mahmood, A., Sarfraz, R. M., Rehman, U., Boublia, A., Alkahtani, A. M., Albakri, G. S., Ijaz, H., Ahmed, S., Haroon, B., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133468 · Cited by 23
Development of pH-sensitive biomaterial-based nanocomposite for highly controlled drug release
Kazemi, B., Javanshir, S., Mahdavinia, G. R., & Naimi‐Jamal, M. R. (2022) · Results in Materials · doi:10.1016/j.rinma.2022.100324 · Cited by 22
Najm, A., Niculescu, A.-G., Bolocan, A., Rădulescu, M., Grumezescu, A. M., Beuran, M., & Gașpar, B. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010043 · Cited by 22
Biomacromolecular carriers based hydrophobic natural products for potential cancer therapy
Pan, W., Gu, F., Yan, X., Huang, J., Liao, H., & Niu, F. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132274 · Cited by 20
Yao, J. L., Mao, L., Wang, C., Liu, X., & Liu, Y. (2023) · Progress in Organic Coatings · doi:10.1016/j.porgcoat.2023.107674 · Cited by 20
Yuwen, T., Zou, H. L., Xu, S., Wu, C., Peng, Q., Shu, D., Yang, X., Wang, Y., Yu, C., Fan, J. Q., et al. (2023) · Materials Today Chemistry · doi:10.1016/j.mtchem.2023.101388 · Cited by 19
Silica nanoparticle design for colorectal cancer treatment: Recent progress and clinical potential
Meng, J., Wang, Z.-G., Zhao, X., Wang, Y., Chen, D.-Y., Liu, D.-L., Ji, C.-C., Wang, T.-F., Zhang, L.-M., Bai, H.-X., et al. (2024) · World Journal of Clinical Oncology · doi:10.5306/wjco.v15.i6.667 · Cited by 18
Vashitha, A., & Khan, S. S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146184 · Cited by 17
Hazra, A., Tudu, M., Mohanta, A., & Samanta, A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131410 · Cited by 17
Zhan, Y.-R., Tan, J., Hei, M.-W., Zhang, S., Zhang, J., & Yu, X. (2022) · Journal of Materials Chemistry B · doi:10.1039/d1tb02602j · Cited by 17
Stimuli-responsive chitosan based nanoparticles in cancer therapy and diagnosis: A review
Fang, G., Peng, H., Qiao, R., Liu, B., Shi, X., Wang, Z., & Sun, P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137709 · Cited by 16
Dual gatekeepers-modified dendritic mesoporous silica nanoparticles for controlled drug release
Zhao, S., Run-hua, T., Deng, S., Chen, G., Ye, J., & Xu, Z. (2023) · Journal of Materials Science · doi:10.1007/s10853-023-09128-5 · Cited by 14
Morais, R. P., de Oliveira, C. C., Riegel-Vidotti, I. C., & Marino, C. E. B. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123689 · Cited by 14
Han, M., Zhou, X., Cheng, H., Qiu, M., Qiao, M., & Geng, X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138800 · Cited by 14
Kumar, D., Gautam, A., & Kundu, P. P. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122735 · Cited by 14
Polysaccharide-functionalized drug delivery system for metastatic cancer therapy
Chen, S., Ye, Y., Pang, S., Li, S., Li, M., Guo, R., & He, Q. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114070 · Cited by 12
Huang, S., Zhou, C. S., Wang, B., Jiang, J., Gao, A., Peng, J., Tang, N., Cui, S., & Cui, D. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104903 · Cited by 12
Huang, W., Zhou, J., Liang, Y., Saladin, R. J., Li, L., Kang, L., Hua, C., & Cai, W. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216641 · Cited by 11
Saravanakumar, K., Sathiyaseelan, A., Manivasagan, P., Zhang, X., Jeong, M. S., Jang, E., & Wang, M. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.129165 · Cited by 10
Advanced oral therapies for colorectal cancer via nanomedicine and microbiota modulation
Wang, Y., Chen, C., Xiao, X. H., Kang, Y., He, J., Beloqui, A., & Xu, Y. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115741 · Cited by 9
Abdelwahab, W., Auclair, S., Borgogna, T. R., Siram, K., Riffey, A., Bazin, H. G., Cottam, H. B., Hayashi, T., Evans, J. T., & Burkhart, D. J. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16010107 · Cited by 9
Hooshyar, M. R., Raygan, S., & Aghdam, R. M. (2024) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-024-06797-9 · Cited by 8
T7 Peptide-modified macrophage membrane-coated nanoplatform for enhanced glioma treatment
Sun, X., Xie, D., Lou, Z., Zhou, Y., Li, M., Li, Q., & Cai, Y. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114527 · Cited by 8
Özkahraman, B., Storozhuk, L., Guo, D., Tung, L. D., Mourdikoudis, S., & Thanh, N. T. K. (2026) · Nanoscale · doi:10.1039/d5nr04770f · Cited by 7
Capecitabine in the modern management of colon cancer: Clinical outcomes and perspectives
Sharma, N., Garg, Y., Sahoo, N. R., Saxena, S., Kumar, S., Singh, A., & Singh, A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106545 · Cited by 7
Glyco-nanomaterials as a therapeutic target in drug delivery and biomedicine: A review
Dessai, A. D., Nair, A., Selvasudha, N., Garg, S., & Nayak, U. Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147830 · Cited by 7
Self-citationLi, W., Liu, D., Song, L., Li, H., Dai, S., Su, Y., Li, Q., Li, J., & Zheng, T. (2022) · Food & Function · doi:10.1039/d2fo00101b · Cited by 7
Li, Z., Che, T., Yang, M., & Hu, X. (2022) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2022.2119286 · Cited by 7
Hou, Y., Wu, J., Bing, J., Zhang, Y., Zhang, J., Zhang, Y., Gao, J., Sun, X., & Dong, Z. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102509 · Cited by 6
Applications of metal oxide nanoparticles in cancer therapy
Mondal, A., Paul, P., & Banerjee, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88450-1.00013-2 · Cited by 6
pH-responsive alliin delivery system: sustained intestinal release
Zhu, Y., Chen, Y., Yao, Y., Li, X., & Wang, M. (2025) · Journal of Food Engineering · doi:10.1016/j.jfoodeng.2025.112670 · Cited by 6
Chitosan conjugates in precision medicine: from synthesis to their role in advanced drug delivery
Khan, O., Bhawale, R., Vasave, R., & Mehra, N. K. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151010 · Cited by 4
Engineering silica nanoparticle-based drug delivery systems for glioblastoma therapy
Munasir, M., Maulana, S. A., Nurlaili, R. A., Taufiq, A., Faaizatunnisa, N., Ariesta, M. N., Suaebah, E., Putri, N. P., Sunaryono, Astuti, S. D., et al. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108178 · Cited by 4
Zhao, N., Chen, H., Cai, S., Li, Q., Wang, J., Wang, W., & Lv, C. (2025) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.121608 · Cited by 4
Carbohydrate polymers in cancer theranostics: Smart solutions for advanced diagnosis and therapy
Rajesh, P., Kaur, H., Ahuja, V., Sharma, D., & Abdi, G. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214522 · Cited by 4
DMTMM‐mediated grafting reaction of glucuronic acid on chitosan
Li, A., Ye, Y., Gong, P., Xiao, B., & Jiang, B. (2022) · Journal of Applied Polymer Science · doi:10.1002/app.53318 · Cited by 4
Incorporation of Capecitabine Into Extended Chain of N‐Acylated Chitosan Carrier
Marlina, A., Misran, M., & Restu, W. K. (2024) · Advances in Polymer Technology · doi:10.1155/2024/1990903 · Cited by 4
Shishira, P. S., Paul, M., & Biswas, S. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106700 · Cited by 3
Guo, Z., He, T., Lou, Y., Xu, G., & Jia, Q. (2025) · Journal of Composites Science · doi:10.3390/jcs9080421 · Cited by 3
Mesoporous silica nanoparticles-based stimuli-triggered drug release systems
Salve, R., Kumar, P., Gajbhiye, K. R., Shende, R. A., Chaudhari, B. P., & Gajbhiye, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824456-2.00007-2 · Cited by 3
Gao, M., Li, L., & Gao, Y. (2022) · Security and Communication Networks · doi:10.1155/2022/1496170 · Cited by 3
RetractedNanotechnology a Boon for Colorectal Cancer Treatment
Kriplani, P., & Guarve, K. (2022) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892817666221011094619 · Cited by 3
Mannose-functionalized Nano-Therapeutics: A targeted strategy for combating bacterial infections
Sajeev, D., Shenoy, P. A., & Nayak, U. Y. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107924 · Cited by 2
Self-citationWang, H., Chen, G., Song, R., Wang, F., Chen, Y., Wang, L., Lei, J., & Liu, J. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.125376 · Cited by 2
Deshmukh, R., Simran, S., Harwansh, R. K., Misra, A., Mishra, S., & Kumar, R. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106338 · Cited by 2
Emerging trends of mesoporous silica nanoparticles in colon targeting
Patel, L., Shah, S., Chauhan, S., Rani, M., Patel, M., & Mehta, T. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24806-1.00016-9 · Cited by 2
Ravinayagam, V., Alomari, M., Tanimu, G., AlAbdullatif, A. A., Dafalla, H., & Jermy, B. R. (2025) · Arabian Journal of Chemistry · doi:10.25259/ajc_104_2024 · Cited by 1
Morais, R. P., Guidi, A. C., de Lima, C. B., de Mello, J. C. P., de Oliveira, C. C., Riegel-Vidotti, I. C., & Marino, C. E. B. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107823 · Cited by 1
Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy
Zaidi, Z. S., Teki, S. V. N., & Katti, D. S. (2026) · Springer eBooks · doi:10.1007/978-981-95-2744-1_8 · Cited by 1
Cai, X., Cui, Y. R., Ding, C., Liu, Y., & Li, T. Y. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02727-1 · Cited by 1
Intelligent theranostic nanoplatforms in next-generation precision oncology
Deng, X., Jiang, C., Li, Y., Su, Q., Xie, K., & Zhao, L. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.180632 · Cited by 1
Functionalized Mesoporous Silica-Based Nanoparticles for Theranostic Applications
Ramteke, U., Kumar, V., Batheja, S., Phulmogare, G., & Gupta, U. D. (2023) · Springer eBooks · doi:10.1007/978-981-99-0538-6_16 · Cited by 1
Yang, N., & Chang, Y. (2024) · Pharmacognosy Magazine · doi:10.1177/09731296241276584 · Cited by 1
Silica and Non-Silica-Based Core-Shell Nanoconstructs for Cancer Theragnostics
Naik, G. A. R. R., Rachana, S. P., Colaco, V., Hedayat, P., Roy, A. A., Pokale, R., Jadhav, S. R., Mukharya, A., Kudarha, R. R., Mutalik, S., et al. (2025) · Springer eBooks · doi:10.1007/978-981-96-3025-7_16 · Cited by 1
Mainuddin, Kumar, A., Sharma, A., & Sharma, N. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128321020240903100601 · Cited by 1
Ravinayagam, V., & Jermy, B. R. (2023) · Springer eBooks · doi:10.1007/978-981-99-6940-1_3
Future perspectives of mesoporous silica-based nanocarriers in drug delivery
Kumar, R., Harilal, S., Vakili‐Ghartavol, R., & Appukuttan, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24802-3.00008-1
Mesoporous silica nanoparticles for therapeutic uses: From bench to clinics
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24802-3.00007-x
Porous silicon-based drug delivery carriers in cancer management
Sharma, B., Yadav, A., Jain, S., Singh, N. K., Gupta, S., Singh, S., & Singh, A. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24802-3.00006-8
The Gastrointestinal Tract: A Unique Battlefield for Bioengineering Delivery Platforms
Ma, T., & Sun, S. (2025) · Bioengineering · doi:10.3390/bioengineering12121347
Avanços recentes das abordagens nanotecnológicas para diagnóstico e tratamento do cancro colorretal
Serrano, D. A. C. (2021) · Lusophone University Repository
Chitosan-Based Light-Activated Drug Delivery System
Najafi, H., Rahimian, S., Doroudian, M., & Farjadian, F. (2025) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-032-08347-0_9
Pagar, S. A., & Thombre, N. A. (2026) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2026v18i1.55787
Micro/nano-modulation of inflammatory signaling pathways in cancer
Wu, X., Wu, Y., Wang, C., Qu, H., & Liu, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36649-9.00007-4
Patra, S., Suman, S., Shetty, P., Shinto, A. S., & Chakraborty, S. (2026) · Chemical Engineering and Processing - Process Intensification · doi:10.1016/j.cep.2026.111038
Abbasi, U., Saifuddin, M., Fatima, M., Gupta, G., Goh, K. W., Sahebkar, A., & Kesharwani, P. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2026.2735989
Xie, Y., Gu, Y., Jiang, Q., Gerhard, M., Zhang, J., Zhao, J., Zhao, J., & Gao, J. (2026) · Nanoscale Advances · doi:10.1039/d6na00583g
Metadata
- Authors
- Narayan, R., Gadag, S., Cheruku, S. P., Raichur, A. M., Day, C. M., Garg, S., Manandhar, S., Pai, K. S. R., Suresh, A., Mehta, C. H., Nayak, Y., Kumar, N., & Nayak, U. Y.
- Affiliations
- Manipal Academy of Higher Education (IN)
- Indian Institute of Science Bangalore (IN)
- University of South Australia (AU)
- Corresponding author
- Nayak, Usha Yogendra
- ORCID
- Venue
- Carbohydrate Polymers
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 261
- Pages
- 117893
- ISSN
- 0144-8617 (ISSN-L)
- OpenAlex
- W3135707793
- Cited by
- 103
- References
- 71
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 21 · 2023: 17 · 2022: 19 · 2021: 8
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Carbohydrate Polymers (publishedVersion)
- PubMed (publishedVersion)
- UniSA Research Outputs Repository (University of South Australia) (acceptedVersion)
- NOT FOUND REPOSITORY (Indian Institute of Science Bangalore) (acceptedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Materials Chemistry › Mesoporous Materials and Catalysis
- Keywords
- mesoporous silica nanoparticles, capecitabine, colorectal cancer, pH-responsive drug delivery, receptor-targeted drug delivery, controlled drug release, HCT116 cells, tumor growth inhibition, aberrant crypt foci, dysplasia, inflammation
- MeSH terms
- Capecitabine, Animals, Cell Survival, Delayed-Action Preparations, Drug Carriers, Female, Humans, Hydrogen-Ion Concentration, Particle Size, Silicon Dioxide, Colorectal Neoplasms, Porosity, Drug Delivery Systems, Rats, Wistar, Coated Materials, Biocompatible, Glucuronic Acid, Xenograft Model Antitumor Assays, HCT116 Cells, Cell Line, Tumor, Chitosan, Rats, Nanoparticles, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
